Cyfuse Biomedical KK (TSE:4892) Operating Cash Flow per Share : 円0.00 (TTM As of Dec. 2023)

View and export this data going back to 2022. Start your Free Trial

What is Cyfuse Biomedical KK Operating Cash Flow per Share?

Cyfuse Biomedical KK's operating cash flow per share for the three months ended in Dec. 2023 was 円0.00. Cyfuse Biomedical KK's operating cash flow per share for the trailing twelve months (TTM) ended in Dec. 2023 was 円0.00.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -20.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Cyfuse Biomedical KK's Operating Cash Flow per Share or its related term are showing as below:

TSE:4892' s 3-Year OCF Growth Rate Range Over the Past 10 Years
Min: -20.5 Med: -20.5 Max: -20.5
Current: -20.5

During the past 4 years, Cyfuse Biomedical KK's highest 3-Year average Operating Cash Flow per Share Growth Rate was -20.50% per year. The lowest was -20.50% per year. And the median was -20.50% per year.

TSE:4892's 3-Year OCF Growth Rate is ranked worse than
82.28% of 807 companies
in the Drug Manufacturers industry
Industry Median: 7.8 vs TSE:4892: -20.50

Cyfuse Biomedical KK Operating Cash Flow per Share Historical Data

The historical data trend for Cyfuse Biomedical KK's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cyfuse Biomedical KK Operating Cash Flow per Share Chart

Cyfuse Biomedical KK Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Operating Cash Flow per Share

-41.15

322.43

-151.27

-71.98

Cyfuse Biomedical KK Quarterly Data
	Dec20	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Operating Cash Flow per Share	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Cyfuse Biomedical KK's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Cyfuse Biomedical KK's Price-to-Operating-Cash-Flow falls into.

Cyfuse Biomedical KK Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Cyfuse Biomedical KK's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (A: Dec. 2023 )	=	Cash Flow from Operations (A: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2023 )
	=	-562.296	/	7.812
	=	-71.98

Cyfuse Biomedical KK's Operating Cash Flow per Share for the quarter that ended in Dec. 2023 is calculated as

Operating Cash Flow per Share (Q: Dec. 2023 )	=	Cash Flow from Operations (Q: Dec. 2023 )	/	Shares Outstanding (Diluted Average) (Q: Dec. 2023 )
	=	0	/	7.894
	=	0.00

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.00

Cyfuse Biomedical KK Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Cyfuse Biomedical KK's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Cyfuse Biomedical KK (TSE:4892) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cyfuse Biomedical KK (TSE:4892) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

3-5-27, Mita, West Wing-1st Floor. Sumitomo Fudosan Mita Twin Building, Minato-ku, Tokyo, JPN

Website

https://www.cyfusebio.com

Cyfuse Biomedical KK is engaged in the development, manufacturing, and sales of regenerative medicine related products.

Cyfuse Biomedical KK (TSE:4892) Headlines

No Headlines